Back to Agenda
Session 4: Crisis Management: How Companies Moved From Emergency Plans to a New Status Quo With COVID-19 and Closing Remarks
Session Chair(s)
Marta Avellar, MBA
MBA, Medical Information Regional Head, LATAM & Canada, Takeda, Brazil
Barbara Nardi, PharmD
Director of Operations Medical Communications, Thermo Fisher Scientific, Brazil
Crisis Management has always been a part of Medical Information Operations. In light of the current COVID-19 crisis, how operations are changing and adapting to this new world is of utmost importance. This session will focus on an overview of strategies and recommendations for collectively addressing the COVID-19 pandemic.
Learning Objective : - Explain how operations are changing to handle the current COVID-19 crisis and the strategies companies are utilizing
- Identify customers’ concerns and behaviors during the crisis and how teams are capturing customers’ needs
- Identify how companies are building the new world – post COVID-19: adapting to working from home, managing teams, and resources
Speaker(s)
Speaker
Bruna Semendri De Vivo, MBA
Operations Head, ePharma, Brazil
Speaker
Paulo Roberto Gomes Takey, DRSc, PharmD, MSc, RPh
Qualified Person Responsible for Pharmacovigilance & Medical Devices Vigilance, Bio-Manguinhos/Fiocruz, Brazil
Speaker
Maria Beatriz Bastos Lucchesi, MBA, MSc
Pharmacovigilance Manager, Butantan Institute, Brazil
Speaker
Vera Gattás, DrMed, MPH
QPPV, Instituto Butantan , Brazil
Speaker
Trudy Burdette, BSN, RN
Associate Director of Operations, PPD, United States
Have an account?